Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00015210 · ClinicalTrials.gov registry record · Phase 2
Nefazodone in the Treatment of Cocaine Dependence and Depression - 4
A Phase 2 study, sponsored by Boston Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 69
- Enrollment target
NCT00015210 is a Phase 2 study that has completed, run by Boston Medical Center. The registered enrollment target is 69 participants.
The verdict
NCT00015210, a Phase 2 study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 69 participants
- Enrollment target
Study Summary
The purpose of this study is the use of Nefazodone in the treatment of cocaine dependence and depression comorbidity.
Interventions
- BEHAVIORAL Psychosocial Treatment
- DRUG Nefazodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 1997-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00015210
The ClinicalTrials.gov registry entry for NCT00015210 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Psychosocial Treatment is the first listed.
NCT00015210 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00015210 about?
NCT00015210 is a clinical study titled "Nefazodone in the Treatment of Cocaine Dependence and Depression - 4". The purpose of this study is the use of Nefazodone in the treatment of cocaine dependence and depression comorbidity.
What is the current status of trial NCT00015210?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 69 participants. The study started on 1997-02.
What interventions are being tested in trial NCT00015210?
The interventions under investigation include: Psychosocial Treatment (BEHAVIORAL), Nefazodone (DRUG).
Who is sponsoring clinical trial NCT00015210?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.